Cary Street Partners Investment Advisory LLC Bausch Health Companies Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 22, 2024	BUY	$6.1 - $10.41 $20,801 - $35,498	3,410 New	3,410 $23,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $4,567 - $5,947	750 New	750 $4,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$257 Million
2.88% of portfolio
Goldentree Asset Management LP New York, NY

29.4M
Shares

$217 Million
21.8% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$195 Million
14.7% of portfolio
National Bank Of Canada

15.6M
Shares

$116 Million
0.18% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$96.1 Million
0.26% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account